Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

THC Biomed Intl Ltd C.THC

Alternate Symbol(s):  THCBF

THC Biomed Intl Ltd. is a Canada-based cannabis producer. The Company’s principal business is the production and sale of cannabis through THC BioMed Ltd., which is a small batch Licensed Producer as regulated by the Cannabis Act which regulates the production, distribution, and possession of cannabis for both medical and adult recreational access in Canada. The Company’s biological assets consist of cannabis plants (mother plants and clones for growth); resin; oil; harvested marijuana flowers prior to completion of the drying, grading and testing processes; and edible concentrate. The Company operates in a single reportable segment being the cultivation and sale of cannabis. Its subsidiaries include THC BioMed Ltd., Clone Shipper Ltd., THC BioMed Victoria Falls Ltd., THC2GO Dispensaries Ltd. (THC2GO), and THC BioMed Lesotho Ltd. (THC Lesotho). Clone Shipper Ltd. owns all rights to the Clone Shipper product used to transport live plants.


CSE:THC - Post by User

Comment by Walterthedogon Nov 24, 2020 5:03pm
115 Views
Post# 31965826

RE:RE:Biden transition news bumped price

RE:RE:Biden transition news bumped priceHaha. I believe he wants, maybe dilution? In retrospect, this financing deal is not the end of the world. We create roughly 15M more shares for 1.5M$ that we obviously need to pay bills and expand our 2.0 product line. The fact that echelon just accepted 366 000 shares at 11 cents for the second tranche when the market value was 9 cents makes me think they have done their homework and believe the SP is going to rise. I don't think these guys are like Alumina, who got 25% below market value and to the best of my knowledge had no lock up on the shares so they could dump them immediately at a profit. And its good to note that for an entire year we did 0 dilution and even attempted to reduce outstanding shares. Get the new products out, make em cheap enough to gain market share and make some money. This is the way. We never could have survived just selling weed. 2.0 has better margins and is easier to scale. Also, not every company out there is equipped to compete in that arena. It would be nice to have some indication of how much KISS we are moving but I doubt we will know those figures until there is something to brag about.
<< Previous
Bullboard Posts
Next >>